FDA inspection
Bostal Drug Delivery Co., Ltd.: FDA inspection ending Nov 15, 2024
FDA inspection 1256930 · Voluntary Action Indicated (VAI) · Guangzhou
Key facts
| Inspection ID | 1256930 |
|---|---|
| Firm | Bostal Drug Delivery Co., Ltd. |
| FEI number | 3003548131 |
| Address | Ruixiang Road Facility, No. 228 Ruixiang Road; Guangzhou Jingjikaifa Huangpu |
| City | Guangzhou |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Nov 15, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data